West Pharmaceutical Services PE Ratio 2010-2024 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of April 26, 2024 is 47.05.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-26 360.43 59.77
2024-03-31 395.51 $6.03 65.59
2023-12-31 351.75 $7.88 44.64
2023-09-30 374.82 $7.41 50.58
2023-06-30 381.88 $6.86 55.67
2023-03-31 345.75 $7.28 47.49
2022-12-31 234.69 $7.72 30.40
2022-09-30 245.18 $8.29 29.58
2022-06-30 301.08 $9.01 33.42
2022-03-31 408.77 $9.00 45.42
2021-12-31 466.56 $8.70 53.63
2021-09-30 422.14 $8.06 52.38
2021-06-30 356.91 $6.84 52.18
2021-03-31 279.91 $5.58 50.16
2020-12-31 281.27 $4.58 61.41
2020-09-30 272.76 $4.13 66.04
2020-06-30 225.27 $3.79 59.44
2020-03-31 150.83 $3.46 43.59
2019-12-31 148.77 $3.20 46.49
2019-09-30 140.19 $3.05 45.96
2019-06-30 123.56 $3.03 40.78
2019-03-31 108.66 $2.90 37.47
2018-12-31 96.52 $2.75 35.10
2018-09-30 121.41 $2.06 58.94
2018-06-30 97.49 $2.00 48.75
2018-03-31 86.56 $1.76 49.18
2017-12-31 96.60 $1.99 48.54
2017-09-30 94.10 $2.51 37.49
2017-06-30 92.27 $2.34 39.43
2017-03-31 79.54 $2.43 32.73
2016-12-31 82.55 $1.92 43.00
2016-09-30 72.37 $1.85 39.12
2016-06-30 73.60 $1.37 53.72
2016-03-31 67.12 $1.15 58.37
2015-12-31 58.19 $1.30 44.76
2015-09-30 52.18 $1.28 40.76
2015-06-30 55.90 $1.69 33.08
2015-03-31 57.83 $1.83 31.60
2014-12-31 51.03 $1.76 28.99
2014-09-30 42.80 $1.66 25.78
2014-06-30 40.23 $1.60 25.14
2014-03-31 41.92 $1.51 27.76
2013-12-31 46.59 $1.58 29.49
2013-09-30 39.00 $1.55 25.16
2013-06-30 33.21 $1.40 23.80
2013-03-31 30.60 $1.19 25.71
2012-12-31 25.71 $1.15 22.45
2012-09-30 24.83 $1.12 22.27
2012-06-30 23.54 $1.15 20.56
2012-03-31 19.74 $1.21 16.38
2011-12-31 17.53 $1.08 16.23
2011-09-30 17.06 $0.90 18.95
2011-06-30 20.04 $0.91 22.03
2011-03-31 20.43 $0.94 21.85
2010-12-31 18.72 $0.94 19.92
2010-09-30 15.52 $1.15 13.55
2010-06-30 16.43 $1.14 14.41
2010-03-31 18.82 $1.12 16.88
2009-12-31 17.51 $1.06 16.52
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.255B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.42
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.255B 44.92
Cooper (COO) United States $17.658B 26.72
Labcorp (LH) United States $16.691B 14.40
Henry Schein (HSIC) United States $9.396B 16.25
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.026B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91
Biolase (BIOL) United States $0.005B 0.00